Healthcare Regulations & Licensing Flashcards

Under DHA regulations, a facility wishes to hire a nurse who holds dual licensure from both the UK (NMC) and Canada (CRNBC). The nurse's UK registration lapsed 14 months ago due to non-renewal, but the Canadian license remains active. Which outcome is most accurate regarding DHA primary source verification (PSV)?

Answer: PSV must be completed for both the UK and Canadian licensing bodies, and the lapsed UK license will trigger a mandatory gap explanation letter before DHA can proceed.

DHA's primary source verification policy requires PSV for all licenses held by the applicant, active or lapsed, from every jurisdiction where the applicant was ever licensed. A lapsed license does not automatically disqualify the applicant, but DHA requires a gap/explanation letter to confirm there were no disciplinary actions or fitness-to-practice findings before the license lapsed. Only after satisfactory PSV and gap documentation can the process continue.

A DHA-licensed specialist physician wishes to perform a procedure that falls outside the scope listed on their DHA license but within their overseas board certification. The facility's CMO approves the procedure internally. Under DHA's scope-of-practice framework, what is the most legally accurate characterization of this situation?

Answer: The procedure constitutes unlicensed practice under DHA jurisdiction regardless of the CMO's approval, as DHA scope is defined on the license itself.

In Dubai, the DHA license explicitly defines the permitted scope of practice for each practitioner. A facility's internal credentialing or CMO approval cannot override or expand the regulatory scope granted by DHA on the license. Performing procedures outside the DHA-approved scope—even with institutional sign-off—is considered unlicensed practice for that specific activity and exposes both the physician and the facility to regulatory sanctions. The physician must first apply for a scope amendment and receive DHA approval before performing such procedures.

A DHA-licensed pharmacy is acquired by a new corporate owner. The existing license is still valid for another 18 months. Under DHA licensing regulations, which statement best reflects the correct regulatory obligation upon change of ownership?

Answer: A change of ownership constitutes a material change that voids the existing license; the new entity must obtain a fresh DHA facility license before or immediately upon the ownership transfer.

A DHA healthcare facility license is issued to a specific legal entity. A change of ownership is a material change that legally invalidates the existing license because the licensed entity no longer owns the facility. The new corporate owner must apply for and receive a new facility license from DHA. Continuing to operate under the former owner's license after ownership transfer is a regulatory violation, even if the pharmacist-in-charge has not changed.

Under the DHA Health Professionals Classification and Scope of Practice guidelines, a practitioner classified as a 'Specialist' seeks promotion to 'Consultant' grade. The practitioner has 7 years of post-fellowship experience in Dubai, strong performance appraisals, and two peer-reviewed publications. Which criterion is most likely to be the decisive barrier to reclassification under current DHA policy?

Answer: DHA requires a minimum of 10 years of post-fellowship experience in the specific specialty for Consultant classification, regardless of regional experience.

DHA's classification framework for Consultant grade specifies a minimum of 10 years of post-fellowship/post-board-certification experience in the relevant specialty. Seven years—even with excellent appraisals and publications—does not meet this threshold. Publications and performance are supporting criteria but cannot substitute for the minimum experience requirement. The 10-year mark is the most commonly misunderstood and overlooked criterion when practitioners seek reclassification.

A DHA-licensed physiotherapist independently sets up a home-visit practice, treating patients in their residences without affiliation to any licensed facility. The physiotherapist holds a valid DHA individual license. Under DHA regulations, which of the following is the most accurate assessment?

Answer: This requires a separate DHA home healthcare facility license or affiliation with a licensed home healthcare provider in addition to the individual license.

An individual DHA license authorizes the practitioner to practice, but practice must occur within a DHA-licensed healthcare setting. Providing clinical services through independent home visits constitutes operating a home healthcare service, which requires either a separate DHA home healthcare facility license for the practitioner's own entity, or formal affiliation with an already-licensed home healthcare provider. The individual license alone does not authorize independent home-based clinical practice as a service model.

During a DHA inspection, a hospital is found to have a patient who has been voluntarily admitted to the psychiatric unit for 45 days. The treating psychiatrist has not filed any periodic review documentation with DHA as required under the Mental Health Law applicable in Dubai. The hospital argues the patient consented verbally at each weekly ward round. What is the most precise regulatory finding here?

Answer: A violation has occurred because Dubai's mental health legislation requires formal written periodic review documentation submitted to the regulatory authority for voluntary admissions exceeding 30 days.

Under the Mental Health Law applicable in Dubai (Federal Law No. 28 of 2021 and DHA implementing regulations), voluntary psychiatric admissions beyond 30 days require formal periodic review with written documentation filed with the relevant health authority. The treating team must conduct and document a structured reassessment confirming the continued appropriateness of inpatient care, the patient's ongoing consent, and the treatment plan. Verbal agreement at ward rounds does not satisfy the regulatory documentation and reporting requirement. Failing to submit this documentation constitutes a compliance violation regardless of the patient's expressed satisfaction.